Shares of state-run Bank of Baroda (BoB) experienced a notable decline of 4.60% today, hitting a low of Rs 259 in afternoon trade. This sharp fall followed the bank's announcement to stock exchanges regarding an out-of-court settlement with the joint administrators of NMC Health PLC, NMC Healthcare Ltd, and NMC Holding Ltd.
The settlement, which resolves claims under ADGM (Abu Dhabi Global Market) and UK insolvency law, as well as UAE civil law, involves a substantial payment of $600 million (approximately Rs 5,700 crore) from Bank of Baroda's Abu Dhabi branch. The bank clarified that all claims and causes of action between the parties have been resolved without any admission of liability or wrongdoing by BoB. The specific terms of the settlement agreement remain confidential.
Background to the Proceedings
The legal proceedings in the ADGM commenced with a trial on March 23, 2026. Concurrently, English proceedings related to the case had been stayed, pending the outcome of the ADGM process. Following the settlement agreement, Bank of Baroda confirmed that the ADGM proceedings have been discontinued, and steps are underway to discontinue the English proceedings as well. The bank's liability in these extensive proceedings is explicitly limited to the agreed settlement sum.
Market Context and Analyst View
Despite the immediate impact of the settlement on Bank of Baroda's stock price, the broader Indian banking sector continues to demonstrate robust health. According to Anand Rathi Share and Stock Brokers, credit growth is accelerating, asset quality remains stable, and return ratios are holding strong. System-wide credit growth saw a 17.7% year-on-year increase in May 2026, marking the ninth consecutive month of acceleration, with public sector banks, including BoB, often outperforming their private counterparts.
Anand Rathi maintains a positive outlook on Bank of Baroda, having assigned a 'Buy' rating on the stock with a target price of Rs 329, viewing it as one of their top picks in the sector.